Cancer (Tumor) Profiling-Global Market Status and Trend Report 2015-2026

Table Of Contents

Chapter 1 Overview of Cancer (Tumor) Profiling 1.1 Definition of Cancer (Tumor) Profiling in This Report 1.2 Commercial Types of Cancer (Tumor) Profiling 1.2.1 Immunoassay 1.2.2 NGS 1.2.3 Mass Spectrometry 1.2.4 Others 1.3 Downstream Application of Cancer (Tumor) Profiling 1.3.1 Clinical 1.3.2 Research 1.4 Development History of Cancer (Tumor) Profiling 1.5 Market Status and Trend of Cancer (Tumor) Profiling 2015-2026 1.5.1 Global Cancer (Tumor) Profiling Market Status and Trend 2015-2026 1.5.2 Regional Cancer (Tumor) Profiling Market Status and Trend 2015-2026Chapter 2 Global Market Status and Forecast by Regions 2.1 Market Development of Cancer (Tumor) Profiling 2015-2019 2.2 Production Market of Cancer (Tumor) Profiling by Regions 2.2.1 Production Volume of Cancer (Tumor) Profiling by Regions 2.2.2 Production Value of Cancer (Tumor) Profiling by Regions 2.3 Demand Market of Cancer (Tumor) Profiling by Regions 2.4 Production and Demand Status of Cancer (Tumor) Profiling by Regions 2.4.1 Production and Demand Status of Cancer (Tumor) Profiling by Regions 2015-2019 2.4.2 Import and Export Status of Cancer (Tumor) Profiling by Regions 2015-2019Chapter 3 Global Market Status and Forecast by Types 3.1 Production Volume of Cancer (Tumor) Profiling by Types 3.2 Production Value of Cancer (Tumor) Profiling by Types 3.3 Market Forecast of Cancer (Tumor) Profiling by TypesChapter 4 Global Market Status and Forecast by Downstream Industry 4.1 Demand Volume of Cancer (Tumor) Profiling by Downstream Industry 4.2 Market Forecast of Cancer (Tumor) Profiling by Downstream IndustryChapter 5 Market Driving Factor Analysis of Cancer (Tumor) Profiling 5.1 Global Economy Situation and Trend Overview 5.2 Cancer (Tumor) Profiling Downstream Industry Situation and Trend OverviewChapter 6 Cancer (Tumor) Profiling Market Competition Status by Major Manufacturers 6.1 Production Volume of Cancer (Tumor) Profiling by Major Manufacturers 6.2 Production Value of Cancer (Tumor) Profiling by Major Manufacturers 6.3 Basic Information of Cancer (Tumor) Profiling by Major Manufacturers 6.3.1 Headquarters Location and Established Time of Cancer (Tumor) Profiling Major Manufacturer 6.3.2 Employees and Revenue Level of Cancer (Tumor) Profiling Major Manufacturer 6.4 Market Competition News and Trend 6.4.1 Merger, Consolidation or Acquisition News 6.4.2 Investment or Disinvestment News 6.4.3 New Product Development and LaunchChapter 7 Cancer (Tumor) Profiling Major Manufacturers Introduction and Market Data 7.1 Illumina 7.1.1 Company profile 7.1.2 Representative Cancer (Tumor) Profiling Product 7.1.3 Cancer (Tumor) Profiling Sales, Revenue, Price and Gross Margin of Illumina 7.2 Nanostring Technologies 7.2.1 Company profile 7.2.2 Representative Cancer (Tumor) Profiling Product 7.2.3 Cancer (Tumor) Profiling Sales, Revenue, Price and Gross Margin of Nanostring Technologies 7.3 HTG Molecular Diagnostics 7.3.1 Company profile 7.3.2 Representative Cancer (Tumor) Profiling Product 7.3.3 Cancer (Tumor) Profiling Sales, Revenue, Price and Gross Margin of HTG Molecular Diagnostics 7.4 Qiagen 7.4.1 Company profile 7.4.2 Representative Cancer (Tumor) Profiling Product 7.4.3 Cancer (Tumor) Profiling Sales, Revenue, Price and Gross Margin of Qiagen 7.5 Helomics Corporation 7.5.1 Company profile 7.5.2 Representative Cancer (Tumor) Profiling Product 7.5.3 Cancer (Tumor) Profiling Sales, Revenue, Price and Gross Margin of Helomics Corporation 7.6 Neogenomics Laboratories 7.6.1 Company profile 7.6.2 Representative Cancer (Tumor) Profiling Product 7.6.3 Cancer (Tumor) Profiling Sales, Revenue, Price and Gross Margin of Neogenomics Laboratories 7.7 Ribomed Biotechnologies 7.7.1 Company profile 7.7.2 Representative Cancer (Tumor) Profiling Product 7.7.3 Cancer (Tumor) Profiling Sales, Revenue, Price and Gross Margin of Ribomed Biotechnologies 7.8 Caris Life Sciences 7.8.1 Company profile 7.8.2 Representative Cancer (Tumor) Profiling Product 7.8.3 Cancer (Tumor) Profiling Sales, Revenue, Price and Gross Margin of Caris Life Sciences 7.9 Genomic Health 7.9.1 Company profile 7.9.2 Representative Cancer (Tumor) Profiling Product 7.9.3 Cancer (Tumor) Profiling Sales, Revenue, Price and Gross Margin of Genomic Health 7.10 Oxford Gene Technology 7.10.1 Company profile 7.10.2 Representative Cancer (Tumor) Profiling Product 7.10.3 Cancer (Tumor) Profiling Sales, Revenue, Price and Gross Margin of Oxford Gene TechnologyChapter 8 Upstream and Downstream Market Analysis of Cancer (Tumor) Profiling 8.1 Industry Chain of Cancer (Tumor) Profiling 8.2 Upstream Market and Representative Companies Analysis 8.3 Downstream Market and Representative Companies AnalysisChapter 9 Cost and Gross Margin Analysis of Cancer (Tumor) Profiling 9.1 Cost Structure Analysis of Cancer (Tumor) Profiling 9.2 Raw Materials Cost Analysis of Cancer (Tumor) Profiling 9.3 Labor Cost Analysis of Cancer (Tumor) Profiling 9.4 Manufacturing Expenses Analysis of Cancer (Tumor) ProfilingChapter 10 Marketing Status Analysis of Cancer (Tumor) Profiling 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders ListChapter 11 Report ConclusionChapter 12 Research Methodology and Reference 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Reference